Title of article
Antibacterial, antifungal and cytotoxic evaluation of some new quinazolinone derivatives
Author/Authors
Hassanzadeh، F. نويسنده Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R.Iran. , , Jafari، E. نويسنده , , Hakimelahi، GH نويسنده , , Rahmani Khajouei، M. نويسنده Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R.Iran. , , Jalali، M. نويسنده Department of Nutrition, School of Health, Isfahan University of Medical Sciences, Isfahan, I.R.Iran. , , Khodarahmi، GA نويسنده ,
Issue Information
دوماهنامه با شماره پیاپی 0 سال 2012
Pages
8
From page
87
To page
94
Abstract
Quinazolinone ring system is renown because of its wide spectrum of pharmacological activities due to various substitutions on this ring system. In this study, the minimum inhibitory concentration of the synthesized compounds in our laboratory was determined by micro dilution Alamar Blue® Assay against six strains of bacteria (three Gram-positive and three Gram-negative) and three strains of fungi. Following a broth micro dilution minimum inhibitory concentration (MIC) test, Minimum Bactericidal Concentration (MBC) and Minimum Fungicidal Concentration (MFC) tests were performed. Cytotoxic effects of the compounds were measured using the MTT colorimetric assay on HeLa cell line. Results of antimicrobial screening showed that compounds had better bacteriostatic activity against Gram-negative bacteria. Results from MBC revealed that these compounds had more significant bacteriostatic than bactericidal activities. Nearly all screened compounds showed good activity against C. albicans and A. niger. Results from MFC indicated that these compounds had better fungistatic rather than fungicidal activities. The synthesized target molecules were found to exhibit different cytotoxicity in the range of 10 to 100 µM on HeLa cell line. Compounds 6 and 7 exhibited acceptable cytotoxicity approximately 50% at 10 µM concentration.
Journal title
Research in Pharmaceutical Sciences
Serial Year
2012
Journal title
Research in Pharmaceutical Sciences
Record number
1273828
Link To Document